Senior insider sale
HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$336.9K
4.83K shares
What this filing means
CONNAUGHTON BERNADETTE plans to sell 4.83K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $336.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001950047-26-000129
Director
Since Sep 2018
4.83K
Shares to sell
$336.9K
Approx. market value
2K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/5/2022
2KTotal acquired2K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/5/2022 | Restricted Stock Units N/A | 2K | — |
| Total | 2K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
829.00
Market value
$59.4K
12/1/2025
—Completed
Units to sell
2K
Market value
$137.0K
11/10/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2K
Market value
$140.6K
1/5/2026
Total
Units
4.83K
Value
$336.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/1/2025 | 829.00 | $59.4K | — | Completed |
11/10/2025 | 2K | $137.0K | — | Completed |
| Planned — Approximate Date | ||||
1/5/2026 | 2K | $140.6K | NASDAQ | Planned |
| Total | 4.83K | $336.9K | ||